Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NPS Pharmaceuticals Has A Billion Plus Blockbuster On Its Hands
Seeking Alpha
Tuesday, August 13, 2013 - 10:55am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Amarin advances after firm raises rating on shares
The Fly on the Wall
Tuesday, August 13, 2013 - 10:53am
tags:
Amarin, Vascepa
Orexigen Investigated By Class Action Firm
Seeking Alpha
Tuesday, August 13, 2013 - 10:51am
tags:
Orexigen, Class Action Lawsuit
Lower-than-Expected Loss at OncoGenex
Yahoo/Zacks
Tuesday, August 13, 2013 - 10:49am
tags:
earnings, OncoGenex
Eli Lilly Lung Cancer Drug Raises Patient Survival in Trial
Bloomberg
Tuesday, August 13, 2013 - 10:48am
tags:
necitumumab, Eli Lilly, lung cancer
Why Is Novartis in Trouble in Japan?
Wall St. Cheat Sheet
Tuesday, August 13, 2013 - 10:47am
tags:
Japan, Novartis, Diovan
Avanir Pharma to co-promote Merck's diabetes drugs; shares rise
Reuters
Tuesday, August 13, 2013 - 10:42am
tags:
Avanir, Merck, diabetes, Januvia, Janumet, Janumet XR
ADHD Drug Emergencies Quadrupled In 6 Years, Says Government Report
Forbes
Tuesday, August 13, 2013 - 10:05am
tags:
ADHD
Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Bloomberg
Monday, August 12, 2013 - 5:26pm
tags:
GSK, FDA, HIV, ViiV Healthcare, Tivicay, Dolutegravir
SciClone Gets New Subpoena from SEC in FCPA Probe
WSJ Online
Monday, August 12, 2013 - 5:23pm
tags:
SciClone, SEC, FCPA
Teva's Several Billion Dollar NTE Opportunity Largely Overlooked
Seeking Alpha
Monday, August 12, 2013 - 5:22pm
tags:
Teva, Copaxone
Biotechs push to save tax credit for rare-disease medicine makers
Boston Herald, MA
Monday, August 12, 2013 - 5:11pm
tags:
orphan drugs, Orphan Drug Tax Credit
Expedited Drug Approval May Push Up Pharmacyclics' Value And Stock Price
Seeking Alpha
Monday, August 12, 2013 - 5:03pm
tags:
Pharmacyclics, ibrutinib, JNJ, chronic lymphocytic leukemia, mantle cell lymphoma
Albany Molecular says Bristol-Myers stops developing depression drug
Reuters
Monday, August 12, 2013 - 5:01pm
tags:
Albany Molecular Research, Bristol-Myers Squibb, BMS-820836, treatment-resistant depression, depression
Immunomedics Advances Solid Tumor Antibody-Drug Conjugate Programs to Phase II Clinical Trials
Yahoo
Monday, August 12, 2013 - 12:12pm
tags:
Immunomedics, solid tumors, antibody-drug conjugate
FDA: Infections prompt recall of all Specialty Compounding's sterile meds
Fierce Pharma
Monday, August 12, 2013 - 11:56am
tags:
FDA, compounding pharmacies, Specialty Compounding
How Much To Develop A Drug? An Update
Seeking Alpha
Monday, August 12, 2013 - 11:51am
tags:
R&D, AstraZeneca, Bayer, Eli Lilly, Novartis, Pfizer, Regeneron, Roche, Shire, Takeda
Oncologists Continue To Shun Sales Reps More Than Other Docs
Pharmalot
Monday, August 12, 2013 - 11:11am
tags:
oncologists, drug reps, physicians
Sanofi's Looking for a Safe Haven
TheStreet.com
Monday, August 12, 2013 - 11:06am
tags:
Sanofi, China, GSK
Pfizer And Merck Show Revenue Declines; Pipelines Remain Strong
Seeking Alpha
Monday, August 12, 2013 - 10:20am
tags:
Pfizer, Merck, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.